English | Español

Eli Lilly And Company
+ Technology/Innovation
Ruth de Jauregui | Dec 4, 2016

Potential Alzheimer's drug fails to produce significant results
+ Technology/Innovation
Ruth de Jauregui | Dec 4, 2016

Bridging the gap between patients, researchers
+ Community
Robert Hadley | Dec 4, 2016

Patient advocacy, collaboration discussed at Brussels EFPIA meeting
+ Regulatory
Amanda Rupp | Oct 16, 2016

Health experts recommend adjusting expectations related to Alzheimer’s treatment goal
+ Community
Amanda Rupp | Sep 18, 2016

Alzheimer’s Readiness Award granted to Boston mayor, local chapter of Alzheimer’s Association
+ Community
Amanda Rupp | Aug 19, 2016

Lilly announces new promotions, retiree
+ Technology/Innovation
Amanda Rupp | Jul 30, 2016

Potential connection found between Alzheimer’s progression, tau pathology
+ Technology/Innovation
Amanda Rupp | Jul 7, 2016

Jardiance limits kidney disease risk for type 2 diabetes patients with cardiovascular disease

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes